Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Foley & Lardner ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
Personalized Therapy Patent Falls As Patent-Ineligible
In a non-precedential opinion, the Federal Circuit held as patent-ineligible patent claims to personalized therapy to treat patients who would benefit from inhaled nitric oxide treatment
United States
12 Sep 2019
2
Plant Variety Protection Act Now Covers Asexually Reproduced Plants
Applicants can still receive plant patent protection on these varieties, but now have the option of obtaining PVPA protection.
United States
30 May 2019
3
Federal Circuit Invalidates Patented Cancer Therapy
In BTG International Limited v. Amneal Pharmaceuticals LLC, (Fed. Cir. Slip Op. 2019-1147, May 14, 2019), the Federal Circuit held that U.S. Patent No. 8,822,438 ("the ‘438 Patent") was invalid as obvious over the prior art.
United States
30 May 2019
4
PMC Releases "A Consumers Guide To Genetic Health Testing"
The Personalized Medicine Coalition, or the "PMC" is an organization of over 250 members that seeks to promote the understanding and adoption of personalized or precision medicine concepts, services,
United States
21 May 2019
5
ASCs Make Comeback With Multispecialty Ownership Groups
Ambulatory surgery center (ASC) development and ownership has made a comeback after a number of years of stagnation due to an oversupply of centers and poor income growth.
United States
8 Apr 2019
6
The Importance Of Diligence In Orthopedic Recapitalization Transactions
As noted in previous Health Care Law Today blog posts, we have seen an uptick in private equity recapitalization transactions in orthopedics.
United States
10 Jan 2019
7
ACA Strike-Down: Salvaging The BPCIA Via Severability
Justice Reed O'Connor's recent decision, Texas et al. v. U.S. et al., No. 4:18-cv-00167-O (E.D. Tex. Dec. 14, 2018) ...
United States
7 Jan 2019
8
Sneak Preview Of This Week's Business Of Personalized Medicine Summit
This year marks the 15th anniversary of the completion of the Human Genome Project. In the decade and a half that has passed since, the genomic revolution has spurred an immeasurable level...
United States
7 Dec 2018
9
The Business Of Personalized Medicine
This year marks the 15th anniversary of the completion of the Human Genome Project.
United States
9 Nov 2018
10
Federal Circuit Finds Detection Claims Invalid Under 101
In Roche Molecular Systems, Inc. v. Cepheid, the Federal Circuit affirmed the summary judgment decision of the U.S. District Court for the Northern District of California that held nucleotide primer..
United States
12 Oct 2018
11
Health Care Policy Happenings - October 1 - 5, 2018
Alexander: Senate Sends Opioids Legislation Called "Landmark" by Leader McConnell to President – On Wednesday, the U.S. Senate passed by a vote of 98-1, the SUPPORT for Patients and Communities Act,
United States
10 Oct 2018
12
Federal Circuit Takes A Narrow View Of Reasonable Expectation Of Success
The Federal Circuit decision in Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc. addressed several aspects of obviousness doctrine.
United States
10 Oct 2018
13
Blocking Patent Discounts Objective Indicia Of Non-Obviousness
In Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., the Federal Circuit affirmed the district court decision finding four Acorda Orange Book-listed patents for Ampyra® invalid as obvious.
United States
4 Oct 2018
14
USPTO Offers Refund Of Certain Non-Electronic Filing Fees Incurred During DSUEBSO
One of the many concerns raised by the recent outage of the USPTO's electronic filing system was the requirement to pay the surcharge due when a new U.S. application is not filed electronically.
United States
9 Sep 2018
15
Agricultural Bioengineering: The Shifting Landscape
The field of bioengineering is rapidly evolving with new tools that allow for simple, efficient, and highly-specific DNA and RNA editing.
United States
9 Aug 2018
16
The Hobson's Choice Of The Hatch-Waxman Integrity Act
As we noted in this article on PTAB Trial Insights, Senator Hatch (R-UT) has introduced the Hatch-Waxman Integrity Act, which is intended to restore the brand-generic balance ...
United States
22 Jun 2018
17
Are These INOMax Therapeutic Method Claims Directed To A Natural Phenomenon?
Judge Sleet of the U.S. District Court for the District of Delaware invalidated personalized method of treatment claims under 35 USC § 101 as being directed to a natural phenomenon.
United States
21 Feb 2018
18
Over 30% Of New Drug Approvals In 2017 Were Personalized Medicines
The Personalized Medicine Coalition (PMC) recently published its "Personalized Medicine at FDA: 2017 Progress Report" (Report) that highlights drug approval developments and milestones achieved in 2017.
United States
21 Feb 2018
19
When Does An RCE Stop The PTA Clock?
In Novartis v. Lee (Fed. Cir. 2014), the Federal Circuit agreed with the USPTO that "time spent in a continued examination" does not count towards the three years the USPTO ...
United States
14 Feb 2018
20
PTAB Enters Sua Sponte Patent Eligibility Rejections
We've written previously about ex parte decisions of the Patent Trial and Appeal Board (PTAB) affirming patent eligibility rejections that seem to be inconsistent with the USPTO's Subject Matter Eligibility Guidance.
United States
6 Feb 2018
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next